The Gap, Inc. (FRA:GAP)

Revance Therapeutics Statistics

Total Valuation

The Gap has a market cap or net worth of EUR 6.33 billion. The enterprise value is 9.13 billion.

Market Cap	6.33B
Enterprise Value	9.13B

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	Jul 9, 2025

Share Statistics

Current Share Class	373.07M
Shares Outstanding	n/a
Shares Change (YoY)	+0.99%
Shares Change (QoQ)	-0.52%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	193.51M

Valuation Ratios

The trailing PE ratio is 8.17 and the forward PE ratio is 9.17.

PE Ratio	8.17
Forward PE	9.17
PS Ratio	0.47
PB Ratio	2.16
P/TBV Ratio	2.16
P/FCF Ratio	8.17
P/OCF Ratio	5.46
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.65, with an EV/FCF ratio of 11.78.

EV / Earnings	11.78
EV / Sales	0.70
EV / EBITDA	3.65
EV / EBIT	9.10
EV / FCF	11.78

Financial Position

The company has a current ratio of 1.71, with a Debt / Equity ratio of 1.65.

Current Ratio	1.71
Quick Ratio	0.78
Debt / Equity	1.65
Debt / EBITDA	1.88
Debt / FCF	6.24
Interest Coverage	13.15

Financial Efficiency

Return on equity (ROE) is 29.16% and return on invested capital (ROIC) is 8.60%.

Return on Equity (ROE)	29.16%
Return on Assets (ROA)	6.51%
Return on Invested Capital (ROIC)	8.60%
Return on Capital Employed (ROCE)	13.43%
Revenue Per Employee	163,055
Profits Per Employee	9,454
Employee Count	82,000
Asset Turnover	1.35
Inventory Turnover	4.39

Taxes

In the past 12 months, The Gap has paid 276.03 million in taxes.

Income Tax	276.03M
Effective Tax Rate	26.26%

Stock Price Statistics

The stock price has decreased by -14.35% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.35%
50-Day Moving Average	18.19
200-Day Moving Average	20.42
Relative Strength Index (RSI)	43.73
Average Volume (20 Days)	73

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.91

Income Statement

In the last 12 months, The Gap had revenue of EUR 13.37 billion and earned 775.19 million in profits. Earnings per share was 2.03.

Revenue	13.37B
Gross Profit	5.54B
Operating Income	1.03B
Pretax Income	1.05B
Net Income	775.19M
EBITDA	1.47B
EBIT	1.03B
Earnings Per Share (EPS)	2.03

Balance Sheet

The company has 1.96 billion in cash and 4.84 billion in debt, giving a net cash position of -2.88 billion.

Cash & Cash Equivalents	1.96B
Total Debt	4.84B
Net Cash	-2.88B
Net Cash Per Share	n/a
Equity (Book Value)	2.93B
Book Value Per Share	7.83
Working Capital	1.79B

Cash Flow

In the last 12 months, operating cash flow was 1.16 billion and capital expenditures -385.39 million, giving a free cash flow of 775.19 million.

Operating Cash Flow	1.16B
Capital Expenditures	-385.39M
Free Cash Flow	775.19M
FCF Per Share	n/a

Margins

Gross margin is 41.41%, with operating and profit margins of 7.72% and 5.80%.

Gross Margin	41.41%
Operating Margin	7.72%
Pretax Margin	7.86%
Profit Margin	5.80%
EBITDA Margin	11.00%
EBIT Margin	7.72%
FCF Margin	5.80%

Dividends & Yields

This stock pays an annual dividend of 0.57, which amounts to a dividend yield of 3.35%.

Dividend Per Share	0.57
Dividend Yield	3.35%
Dividend Growth (YoY)	3.28%
Years of Dividend Growth	n/a
Payout Ratio	26.17%
Buyback Yield	-0.99%
Shareholder Yield	2.36%
Earnings Yield	12.24%
FCF Yield	12.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 22, 1999. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 22, 1999
Split Type	Forward
Split Ratio	1.5

Scores

The Gap has an Altman Z-Score of 2.85 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.85
Piotroski F-Score	6